Skip to content

Modification to Medamicus Axia RSN

by Medamicus, Inc.

510(k) K022689

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK022689 Date23 Aug 2002ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DYB
Device Class
Class II
Regulation
21 CFR Part 870.1340
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Modification to Medamicus Axia RSN is an embolization coil designed to occlude blood vessels. It works by being delivered via a catheter to the target site, where it expands and induces clot formation, effectively blocking blood flow. This device is used to treat conditions such as aneurysms or arteriovenous malformations.

The MedAmicus Axia RSN is intended to minimize needle stick injuries when used for percutaneous introduction of guidewires or similar devices. It is a Class II device with product code DYB, cleared by the FDA as substantially equivalent on 2002-08-23. The device is manufactured by Medamicus, Inc. and is part of the cardiovascular product category.

Other devices from Medamicus, Inc.

See all devices from Medamicus, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the purpose of the Modification to Medamicus Axia RSN?

    The Modification to Medamicus Axia RSN is an embolization coil designed to occlude blood vessels. It works by being delivered via a catheter to the target site, where it expands and induces clot formation, effectively blocking blood flow to treat conditions such as aneurysms or arteriovenous malformations.

  • How is the MedAmicus Axia RSN device used to minimize needle stick injuries?

    The MedAmicus Axia RSN is specifically designed to minimize needle stick injuries when used for percutaneous introduction of guidewires or similar devices. This safety feature makes it particularly valuable in clinical settings where needle stick injuries are a concern.

  • What is the regulatory status of the Modification to Medamicus Axia RSN?

    The Modification to Medamicus Axia RSN is a Class II device with product code DYB, cleared by the FDA as substantially equivalent on 2002-08-23. It is manufactured by Medamicus, Inc. and is part of the cardiovascular product category.

  • How is the Modification to Medamicus Axia RSN supplied and stored?

    The device is supplied in a sterile condition to ensure safety during medical procedures. It should be stored according to the manufacturer's guidelines to maintain its integrity and functionality until use.